Tresiba (insulin degludec) and Lantus (insulin glargine) are Food and Drug Administration (FDA)-approved synthetic insulins for glycemic control (blood sugar levels) in people with type 1 or type ...

If approved in the US, the titratable combination drug looks likely to compete against Novo Nordisk’s rival IDegLira (insulin degludec+liraglutide), after both received the backing of advisers ...

and Xultophy (insulin degludec/liraglutide). That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine ...

b.i.d.: Twice daily; LEAD: Liraglutide Effect and Action Diabetes ... for the 'incretin effect', a phenomenon in which where more insulin is secreted in response to glucose ingested during ...

A regimen of inhaled Technosphere insulin and insulin degludec is just as good as usual care for glycaemic control, new evidence has indicated. During the study, the team of researchers from the ...